SXTP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.27%

Insider Buying (Last 12 Months): $90,909.60

Insider Selling (Last 12 Months): $0.00

60 Degrees Pharmaceuticals Insider Trading History Chart

60 Degrees Pharmaceuticals Share Price & Price History

^$1.34

▲ +0.02 (1.52%)

As of 12/26/2024 06:36 PM ET

Days: 30 | 90 | 365

Why I'm telling friends to avoid gold stocks

From DTI | Ad

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

60 Degrees Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/16/2024	Cheryl Xu	Director	Buy	2,000	$1.45	$2,900.00	54,078
12/12/2024	Cheryl Xu	Director	Buy	5,000	$1.82	$9,100.00	46,078
12/9/2024	Geoffrey S Dow	CEO	Buy	35,823	$1.27	$45,495.21	94,580
12/5/2024	Geoffrey S Dow	CEO	Buy	17,549	$1.11	$19,479.39	38,178
11/21/2024	Geoffrey S Dow	CEO	Buy	3,500	$0.91	$3,185.00	20,629
11/19/2024	Geoffrey S Dow	CEO	Buy	2,500	$0.90	$2,250.00	16,129
8/27/2024	Cheryl Xu	Director	Buy	5,000	$1.70	$8,500.00	41,078

A brand new opportunity in the stock market revealed

From DTI | Ad

Today, I want to unlock a brand new opportunity in the stock market… One that has been able to pay out around 100% in 5 days or less so far on REAL money… It’s all thanks to a hidden force that drives some of the BIGGEST & most repetitive moves in stocks… I call it a Gamma Pocket…

Will you be the next trader to discover the power of Gamma Pockets?

SEC Filings (Institutional Ownership Changes) for 60 Degrees Pharmaceuticals (NASDAQ:SXTP)

7.96% of 60 Degrees Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

60 Degrees Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/19/2024	Central Bank & Trust Co.	167,000	$42K	0.0%	-37.7%	1.368%
4/11/2024	Central Bank & Trust Co.	268,000	$70K	0.0%	-24.9%	4.613%
1/9/2024	Central Bank & Trust Co.	357,000	$0.36M	0.1%	-23.7%	6.155%

Data available starting January 2016

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia.

Today's Range

Now: $1.34

$1.25

$1.39

50 Day Range

MA: $1.10

$0.72

$2.21

52 Week Range

Now: $1.34

$0.70

$15.00

Volume

144,282 shs

Average Volume

285,742 shs

Market Capitalization

$3.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

5.36

Who are the company insiders with the largest holdings of 60 Degrees Pharmaceuticals?: 60 Degrees Pharmaceuticals' top insider investors include:
Geoffrey S Dow (CEO)
Cheryl Xu (Director)
Learn More about top insider investors at 60 Degrees Pharmaceuticals.